Susan M. Villare - Mar 7, 2023 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
Chief Financial Officer
Signature
/s/ Susan M. Villare
Stock symbol
MRMD
Transactions as of
Mar 7, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 04:42 PM
Previous filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRMD Common stock 350K Mar 7, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Award $0 +60K $0.00 60K Mar 7, 2023 Common Stock, par value $.001 per share 60K Direct F1, F2
holding MRMD Option to buy common stock 400K Mar 7, 2023 Common Stock, par value $.001 per share 400K $0.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs were granted to the Reporting Person in accordance with Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Each RSU represents a contingent right to receive one share of the Issuers common stock RSUs convert to common stock on a one-for-one basis.
F2 The RSUs vest over a three year period of which 20,000 RSUs will vest on March 7, 2024 and thereafter, 10,000 RSUs will vest every succeeding six (6) months through March 7, 2026, on each of September 7th and March 7th, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
F3 Granted to the Reporting Person on May 2, 2022 (the "Grant Date"), this option is exercisable to acquire 100,000 of the underlying shares on the six (6) month anniversary of the Grant Date (the "Initial Vesting Date") and for an additional 100,000 shares on the last day of every succeeding six (6) month period after the Initial Vesting Date until the option is fully vested.